Human pathology

Home page > D. Systemic pathology > Genetic and developmental anomalies > Fabry disease

Fabry disease

Image Gallery

Fabry disease among sphingolipidoses (from 12667757)
Fabry?s disease

Fabry disease is an X-linked generalized progressive debilitating lysosomal storage disorder. The disease usually manifests in childhood, but the diagnosis is often made following the occurrence of late-stage complications such as progressive kidney failure.

Synopsis

- systemic anomalies

  • retarded growth
  • delayed puberty

- ocular anomalies

  • Whorl-like corneal dystrophy in heterozygous females and hemizygous males

- cardiovascular anomalies

  • coronaropathy
  • cerebral vascular anomalies
  • Left ventricular wall and septal hypertrophy
  • Lymphedema
  • Myocardial infarction
  • Valvular disease (mitral)
  • Congestive heart failure

- Mild obstructive lung disease
- Limited extension of terminal joints

- cutaneous anomalies

  • Hypohidrosis
  • Angiokeratoma

- Glycosphingolipid deposition in all areas of the body
- Lipid-laden macrophages in bone marrow

Biology

- Proteinuria
- Alpha-galactosidase A deficiency in plasma, leukocytes, or fibroblasts
- Increased level of globotriaosylceramide in plasma and urinary sediment
- renal sinus cysts (parapelvic kidney cysts) (15327390)

Etiology

- Fabry disease is an X-linked recessive inborn error of glycosphingolipid catabolism due to mutations in the GLA gene that encodes the lysosomal exoglycohydrolase alpha-galactosidase A (alpha-GalA) (MIM.301500)